ALGN vs ISRG: stock comparison and AI forecast
Align Technology Inc (ALGN) and Intuitive Surgical Inc (ISRG) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ALGN Align Technology Inc
- Price
- $166.00 -1.4% · 6M
- Market Cap
- $11.79B
- P/E Ratio
- 24.2x
- Size
- large-cap
- AI Forecast
ISRG Intuitive Surgical Inc
- Price
- $452.80 -0.2% · 6M
- Market Cap
- $156.96B
- P/E Ratio
- 54.9x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- ISRG is 13.3 times larger than ALGN by market capitalization ($156.96B against $11.79B).
- ALGN trades at 24.2 times trailing earnings, ISRG at 54.9 times.
- Over the last six months ISRG returned -0.2% and ALGN -1.4%.
- ISRG turns 25.5% of its revenue into net income, against 11.8% for ALGN.
- ALGN carries 0.51 times debt per unit of equity, against 0.20 times for ISRG.
- Both companies share the SEC industry classification Orthopedic, Prosthetic & Surgical Appliances & Supplies.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ALGN | ISRG |
|---|---|---|
| Market Cap | $11.79B | $156.96B |
| P/E Ratio | 24.20x | 54.89x |
| P/B Ratio | 2.74x | 9.82x |
| EPS | $6.86 | $8.25 |
| Book Value/Share | $60.61 | $46.12 |
| Revenue/Share | $58.54 | $33.40 |
| FCF/Share | $8.48 | $10.38 |
Profitability & Margins
| Metric | ALGN | ISRG |
|---|---|---|
| ROE | 11.4% | 18.5% |
| ROA | 7.5% | 15.3% |
| ROIC | 13.5% | 19.5% |
| Gross Margin | 69.1% | 67.2% |
| Operating Margin | 14.9% | 28.4% |
| Net Margin | 11.8% | 25.5% |
| EBT Margin | 15.5% | 31.3% |
| Tax Rate | 23.6% | 17.9% |
Financial Health
| Metric | ALGN | ISRG |
|---|---|---|
| Current Ratio | 1.42x | 3.33x |
| Quick Ratio | 1.31x | 2.49x |
| D/E Ratio | 0.51x | 0.20x |
| Financial Leverage | 1.51x | 1.21x |
| Interest Coverage | 518.2x | – |
| Working Capital | $813M | $5.90B |
Cash Flow
| Metric | ALGN | ISRG |
|---|---|---|
| Operating Cash Flow | $750M | $4.09B |
| Free Cash Flow | $602M | $3.60B |
| Capital Spending | -$147M | -$492M |
| OCF Growth YoY | 14.3% | 38.1% |
| FCF Growth YoY | 6.3% | 58.4% |
| FCF/Sales | 14.5% | 31.1% |
| CapEx/Sales | 3.5% | 4.2% |
Operational Efficiency
| Metric | ALGN | ISRG |
|---|---|---|
| Asset Turnover | 0.64x | 0.60x |
| Receivables Turnover | 3.6x | 6.7x |
| Inventory Turnover | 5.7x | 1.8x |
| Fixed Assets Turnover | 3.7x | 2.0x |
| Days Sales Outstanding | 102 days | 54 days |
| Days Inventory | 64 days | 204 days |
| Payables Period | 34 days | 27 days |
| Cash Conversion Cycle | 133 days | 232 days |
Income Statement
| Metric | ALGN | ISRG |
|---|---|---|
| Total Revenue | $4.16B | $11.58B |
| Operating Income | $620M | $3.28B |
| Net Income | $492M | $2.96B |
| R&D Expense | $378M | $1.49B |
| SG&A Expense | $1.78B | $2.55B |
| Cost of Goods Sold | $1.28B | $3.80B |
Dividend & Shareholder Information
| Metric | ALGN | ISRG |
|---|---|---|
| Shares Outstanding | 71M | 347M |
| Net Income Growth | 30.0% | 7.7% |
| EPS Growth | 32.7% | 9.0% |
ALGN vs ISRG: stock comparison and AI forecast
Which is bigger, ALGN or ISRG?
ISRG is 13.3 times larger than ALGN by market capitalization ($156.96B against $11.79B).
Which is cheaper on earnings, ALGN or ISRG?
ALGN trades at 24.2 times trailing earnings, ISRG at 54.9 times.
Which stock performed better over the last six months, ALGN or ISRG?
Over the last six months ISRG returned -0.2% and ALGN -1.4%.
Which one does Intratio's AI model rank higher, ALGN or ISRG?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.